logo
Plus   Neg
Share
Email

Beware Of Tainted Weight Loss Pills, Warns FDA

yellowpills-040612.jpg

Consumers are advised not to purchase or use "Japan Rapid Weight Loss Diet Pills", a product for weight loss, as they contain a cancer-causing agent, warns the FDA.

The "Japan Rapid Weight Loss Pills", which are available in three different colors namely, green, yellow and blue, are sold on various websites, such as www.ebay.com, and distributed by a company called Xiushentang.

A laboratory analysis by the FDA has confirmed that these weight loss diet pills contain undeclared Phenolphthalein and Sibutramine.

Phenolphthalein is a chemical capable of potentially damaging or even causing mutations in a person's DNA. The FDA has classified Phenolphthalein as "not generally recognized as safe and effective."

Sibutramine is a substance known to substantially increase blood pressure and/or pulse rate in some patients.

Remember, Abbott Laboratories' obesity drug Meridia, which was pulled off the market in October 2010 due to increased risk of heart attack and stroke? The active ingredient in Meridia was also Sibutramine.

The FDA in a statement said that consumers should stop using these products immediately and throw them away. Consumers who have experienced any negative side effects should consult a health care professional as soon as possible.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Billionaire entrepreneur Elon Musk on Thursday showed off his concept for the Loop, a high-speed underground public transportation system that will carry up to 16 people and travel at 150 miles per hour. At the Boring Company Information Session, Musk and project leader Steve Davis provided details of the underground mass transit tunnels that the Boring Co. plans to build beneath Los Angeles. Raden has become the second smart luggage company to shut down this month after major U.S. airlines banned smart luggage with non-removable batteries earlier this year. In a statement on its website, Raden said that it is no longer in operation and that all existing shipments have been processed for delivery. The company is shuttering after three years of operation. Shares of AstraZeneca were losing around 2 percent in the London trading after the British drug major reported Friday lower profit in its first quarter amid weak margin, despite growth in product sales. Further, the company reiterated its outlook for fiscal 2018. The level of Externalisation Revenue, divestment timing and investment in launches impacted the overall results.
Follow RTT